rs772711535
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001005271.3(CHD3):c.42G>A(p.Glu14Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000757 in 1,115,704 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 25)
Exomes 𝑓: 0.00081 ( 4 hom. )
Consequence
CHD3
NM_001005271.3 synonymous
NM_001005271.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.665
Genes affected
CHD3 (HGNC:1918): (chromodomain helicase DNA binding protein 3) This gene encodes a member of the CHD family of proteins which are characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. This protein is one of the components of a histone deacetylase complex referred to as the Mi-2/NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Chromatin remodeling is essential for many processes including transcription. Autoantibodies against this protein are found in a subset of patients with dermatomyositis. Three alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
NAA38 (HGNC:28212): (N-alpha-acetyltransferase 38, NatC auxiliary subunit) Involved in negative regulation of apoptotic process. Located in cytoplasm and nucleoplasm. Part of NatC complex. Colocalizes with polysome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 17-7884848-G-A is Benign according to our data. Variant chr17-7884848-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 932351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.665 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000383 (57/148738) while in subpopulation SAS AF= 0.00492 (23/4674). AF 95% confidence interval is 0.00336. There are 0 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High AC in GnomAd4 at 57 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD3 | NM_001005271.3 | c.42G>A | p.Glu14Glu | synonymous_variant | Exon 1 of 40 | NP_001005271.2 | ||
CHD3 | XM_005256427.5 | c.42G>A | p.Glu14Glu | synonymous_variant | Exon 1 of 40 | XP_005256484.1 | ||
CHD3 | XM_006721423.4 | c.42G>A | p.Glu14Glu | synonymous_variant | Exon 1 of 40 | XP_006721486.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD3 | ENST00000700753.1 | c.42G>A | p.Glu14Glu | synonymous_variant | Exon 1 of 40 | ENSP00000515165.1 | ||||
CHD3 | ENST00000380358.9 | c.42G>A | p.Glu14Glu | synonymous_variant | Exon 1 of 40 | 2 | ENSP00000369716.4 | |||
NAA38 | ENST00000576861.5 | c.-167+317C>T | intron_variant | Intron 1 of 4 | 3 | ENSP00000461545.1 | ||||
NAA38 | ENST00000570555.1 | n.74+317C>T | intron_variant | Intron 1 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000390 AC: 58AN: 148634Hom.: 0 Cov.: 25
GnomAD3 genomes
AF:
AC:
58
AN:
148634
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00197 AC: 157AN: 79592Hom.: 2 AF XY: 0.00253 AC XY: 113AN XY: 44620
GnomAD3 exomes
AF:
AC:
157
AN:
79592
Hom.:
AF XY:
AC XY:
113
AN XY:
44620
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000815 AC: 788AN: 966966Hom.: 4 Cov.: 13 AF XY: 0.000989 AC XY: 483AN XY: 488584
GnomAD4 exome
AF:
AC:
788
AN:
966966
Hom.:
Cov.:
13
AF XY:
AC XY:
483
AN XY:
488584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000383 AC: 57AN: 148738Hom.: 0 Cov.: 25 AF XY: 0.000524 AC XY: 38AN XY: 72482
GnomAD4 genome
AF:
AC:
57
AN:
148738
Hom.:
Cov.:
25
AF XY:
AC XY:
38
AN XY:
72482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
CHD3: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at